Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAVEL Trial
NL-OMON38234Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remifentanil (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Cost-effectiveness of RPCA versus EA, Costs and 1 more. Started May 2011; status: active, not recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NL-OMON38234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38234.